PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Salmon acyl-ghrelin increases food intake and reduces doxorubicin-induced myocardial apoptosis in rats, likely by anti-oxidative activity.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33340558 ↗2020Reported benefit

Salmon acyl-ghrelin increases food intake and reduces doxorubicin-induced myocardial apoptosis in rats, likely by anti-oxidative activity.

RatChemical/toxinn = Five groups; n per group not statedSubcutaneousGiven for 7 days before doxorubicin administration (pre-treatment)

Model: Doxorubicin-induced acute cardiotoxicity and acute heart failure; doxorubicin 20 mg/kg body weight by intraperitoneal injection after 7 days of pre-treatment

Salmon acyl-ghrelin showed binding affinity similar to rat acyl-ghrelin at GHS-R1a, increased food intake and reduced doxorubicin-induced myocardial apoptosis with antioxidant activity, whereas salmon unacylated-ghrelin did not.

Extraction: extract · Supplied extraction confidence: 0.68. Machine-extracted fields require source verification.